Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis In Myocardial Infarction 38 - TRITON-TIMI 38

Description:

The goal of the trial was to evaluate treatment with a novel thienopyridine, prasugrel, compared with clopidogrel among patients undergoing planned percutaneous coronary intervention (PCI) for an acute coronary syndromes (ACS).